【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.1 Iressa
04.1.2 Abraxane
04.1.3 Alimta
04.1.4 Gemzar
04.1.5 Xalkori
04.1.6 Avastin
04.1.7 Tarceva
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Molecule Type
08.1 Biologics
08.2 Small Molecules
09. Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 AstraZeneca
18.3.1 Iressa
18.4 Celgene
18.4.1 Abraxane
18.5 Eli Lilly
18.5.1 Alimta
18.5.2 Gemzar
18.6 Pfizer
18.6.1 Xalkori
18.7 Roche
18.7.1 Avastin
18.7.2 Tarceva
18.8 Other Prominent Vendors
19. Pipeline Portfolio
20. Key Vendor Analysis
20.1 AstraZeneca plc
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Revenue by Business Segmentation
20.1.6 Revenue Comparison 2011-2013
20.1.7 Sales Revenue by Geographical Segmentation
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Celgene
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Strategy
20.2.4 Business Segmentation by Revenue 2011-2013
20.2.5 Sales by Geography
20.2.6 Key Developments
20.2.7 SWOT Analysis
20.3 Eli Lilly
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Sales by Geography
20.3.6 Business Strategy
20.3.7 Key Developments
20.3.8 SWOT Analysis
20.4 Pfizer
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Business Segmentation
20.4.4 Revenue by Business Segmentation
20.4.5 Revenue Comparison 2012 and 2013
20.4.6 Sales by Geography
20.4.7 Business Strategy
20.4.8 Key Developments
20.4.9 SWOT Analysis
20.5 Roche
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation by Revenue 2013
20.5.4 Business Segmentation by Revenue 2012 and 2013
20.5.5 Geographical Segmentation by Revenue 2013
20.5.6 Business Strategy
20.5.7 Recent Developments
20.5.8 SWOT Analysis
21. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Non-Small-Cell Lung Cancer Market 2013-2018 (US$ billion)
Exhibit 3: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type
Exhibit 4: Global Non-Small-Cell Lung Cancer Market Segmentation by Molecule Type 2013
Exhibit 5: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration
Exhibit 6: Global Non-Small-Cell Lung Cancer Market Segmentation by Route of Administration 2013
Exhibit 7: Global Non-Small-Cell Lung Cancer Market by Geographical Segmentation 2013
Exhibit 8: Global Non-Small-Cell Lung Cancer Market Share Analysis 2013
Exhibit 9: Sales Comparison of Major Drugs 2010-2013 (US$ million)
Exhibit 10: AstraZeneca’s Iressa Sales Comparison 2006-2013 (US$ million)
Exhibit 11: Iressa Sales Comparison in Western Europe 2009-2013 (US$ million)
Exhibit 12: Iressa Sales Comparison in the Established ROW 2009-2013 (US$ million)
Exhibit 13: Iressa Sales Comparison in the Emerging Markets 2009-2013 (US$ million)
Exhibit 14: Region-wise Total Sales Comparison of Iressa 2009-2011 (US$ million)
Exhibit 15: Sales Comparison of Abraxane 2009-2013 (in US$ million)
Exhibit 16: Sales Comparison of Alimta 2003-2011 in the US (US$ million)
Exhibit 17: Sales Comparison of Alimta 2003-2011 Outside the US (US$ million)
Exhibit 18: Total Sales Comparison of Alimta 2003-2011 (US$ million)
Exhibit 19: Region-wise Total Sales Comparison of Alimta 2003-2011 (US$ million)
Exhibit 20: Sales Comparison of Gemzar in the US 2003-2011 (US$ million)
Exhibit 21: Sales Comparison of Gemzar Outside the US 2003-2011 (US$ million)
Exhibit 22: Worldwide Total Sales Comparison of Gemzar 2003-2011 (US$ million)
Exhibit 23: Region-wise Total Sales Comparison of Gemzar 2003-2011 (US$ million)
Exhibit 24: Sales Forecast of Xalkori 2013-2018 (US$ million)
Exhibit 25: Sales Comparison of Avastin and Tarceva 2005-2013 (in US$ million)
Exhibit 26: Sales Comparison of Avastin 2005-2013 (US$ million)
Exhibit 27: Sales Comparison of Tarceva 2005-2013 (US$ million)
Exhibit 28: Late Stage Pipeline Molecules for Non-Small-Cell-Lung Cancer
Exhibit 29: AstraZeneca plc: Business Segmentation
Exhibit 30: AstraZeneca plc: Revenue by Business Segmentation2013
Exhibit 31: AstraZeneca plc: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 32: AstraZeneca plc: Sales Revenue by Geographical Segmentation 2013
Exhibit 33: Celgene Corp.: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 34: Celgene Corp.: Sales by Geography 2013
Exhibit 35: Eli Lilly and Co.: Business Segmentation by Revenue 2013
Exhibit 36: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Eli Lilly and Co.: Sales by Geography 2013
Exhibit 38: Pfizer Inc.: Business Segmentation
Exhibit 39: Pfizer Inc.: Revenue by Business Segmentation 2013
Exhibit 40: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
Exhibit 41: Pfizer Inc.: Revenue by Geography 2013
Exhibit 42: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 43: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 44: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals Division)
Exhibit 45: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics Division)
【レポート販売概要】
■ タイトル：世界の非小細胞肺癌(NSCLC)治療市場：生物学的製剤、分子標的治療■ 英文：Global Non-small Cell Lung Cancer Market 2014-2018
■ 発行日：2014年9月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4123
■ 調査対象地域：グローバル
- 多形性膠芽腫治療薬の世界市場2015-2019About Glioblastoma Multiforme Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and ol …
- 走査型電子顕微鏡（SEM）の世界市場2016-2020About Scanning Electron Microscope The capacity of an optical microscope is limited by the wavelength of the light used to see the object. When it comes to studying the structure and arrangement of atoms and molecules, optical microscopes fall short because their resolution is limited by the wavelength of light. In 1931, Max Knoll and Ernst Ruska invented the electron microscope. They used electro …
- 世界主要国におけるヘルペスマーカー検査市場2015The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for the following markets: …
- 大陸間弾道ミサイル（ICBM）の世界市場2016-2020About the Intercontinental Ballistic Missiles Market Intercontinental Ballistic Missiles are guided ballistic missiles with a minimum range of 3,400 miles, which are designed for the delivery of one or more nuclear warheads. They have greater range and speed than other ballistic missiles, such as intermediate-range ballistic missiles (IRBMs), medium-range ballistic missiles (MRBMs), and short-rang …
- ETCシステムの世界市場：ETC車載器、ETC車両検知器About Electronic Toll Collection Systems An electronic toll collection (ETC) system is a sophisticated application that includes a group of technologies to provide automated non-stop cashless payment of road toll at toll plazas or toll collection center. The system works with various technology-enabled products such as transponders, antennas, sensors, and wireless communication devices equipped wi …
- 凍結治療の世界市場予測（～2024年）“The cryotherapy market is projected to grow at a CAGR of 9.1% during the forecast period.” The cryotherapy market is projected to reach USD 319 million by 2024 from USD 206 million in 2019 at a CAGR of 9.1%. The rising incidence of sports injuries, cardiac conditions, and cancers is driving the growth of the market. Increasing demand for minimally invasive procedures, technological advancements i …
- ウェアラブル・フィットネス技術の世界市場：スマートウォッチ、リストバンド、スマート靴、スマートシャツ、ヘッドバンドThe market for wearable fitness technology is expected to reach USD 12.44 Billion by 2022, at a CAGR of 13.7% between 2016 and 2022. This market is primarily driven by consumer preference for sophisticated gadgets, increasing popularity of wearable fitness and medical devices, increasing awareness about fitness, and rise in disposable incomes in developing economies. The wearable fitness technolog …
- フェイシャルエステティックの世界市場2018-2022About facial aesthetics Facial aesthetics aid in removing wrinkles and improving the aesthetic appeal of the face. Facial aesthetic products are injected under the skin or lips to plump up the tissues and restore the collagen lost due to aging. Technavio’s analysts forecast the Global facial aesthetics market to grow at a CAGR of 8.05% during the period 2018-2022. Covered in this report The report …
- 茶の世界市場：種類別（緑茶、紅茶、ウーロン茶、フルーツ/ハーブティー、その他）、包装別（プラスチック容器、ルーズティー、板紙、アルミ缶、ティーバッグ）、流通経路別（スーパーマーケット/ハイパーマーケット、専門店、コンビニエンスストア、オンラインストア、その他）、用途別（家庭、商業）Tea is the most commonly consumed drink with several health benefits. The aromatic beverage is made via processing and fermentation of Camellia Sinensis plant leaves. It contains potential antioxidants known as flavonoids, which stabilize harmful free radicals in the body. In addition, tea comprises vitamins C, K, B12, B6, & E; trace amount of potassium, manganese, magnesium, & calcium minerals; a …
- 船舶用推進機関の世界市場：ディーゼルエンジン、ガスタービンエンジンAbout Marine Propulsion Engines The first kind of mechanical marine propulsion engines was the steam engines that came into inception during the 19th century. With time, steam engines have been increasingly replaced by two-stroke and four-stroke diesel engines and gas turbine engines from the 20th century onward. The use of LNG (liquefied natural gas) as a fuel in the marine propulsion engine is g …
- 農業用微量栄養素の世界市場：亜鉛、マンガン、ホウ素、銅、モリブデン、鉄The agricultural micronutrients market has grown exponentially in the last few years and this trend is projected to continue. The market was estimated at $4.8 billion in 2014 and is projected to grow at a CAGR of 8.1% from 2015 to 2020; the market is projected to reach $7.6 billion by 2020. The market is primarily driven by the increasing demand for food in tandem with the growing disposable incom …
- 遮断器及びヒューズの世界市場：SF6遮断器、真空遮断器、高圧用/中圧用/低圧用遮断器This report estimates global circuit breakers and fuse market in terms of value in $million and volume in million units. This has been broken down into various geographical regions, application, types, and voltage levels. The report includes a detailed analysis of the market trends and forecasts; competitive landscape; company profiles, and so on. Major regions which have seen some traction for ci …
- 門脈高血庄症（Portal Hypertension）：グローバル臨床試験動向（2014年上半期）Portal Hypertension Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H1, 2014" provides data on the Portal Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Portal Hypertension. It includes an overview of the trial numbers and their recru …
- L-(-)-カルニチンHCllの世界市場L-(-)-Carnitine HCl (CAS 6645-46-1) Market Research Report 2013 presents comprehensive data on l-(-)-carnitine hcl markets globally and regionally (Europe, Asia, North America etc.) The L-(-)-Carnitine HCl (CAS 6645-46-1) Market Research Report 2013 includes l-(-)-carnitine hcl description, covers its application areas and related patterns. It overviews l-(-)-carnitine hcl market, names l-(-)-carn …
- 鉄筋の世界市場2016-2020About Steel Rebars Rebars are used as tensile devices in reinforced concrete to give strength and hold the concrete in tension. Apart from strength, rebars are used to absorb energy, adapt to extreme conditions, and hold stress during natural disasters. The market is anticipated to grow at a rapid pace due to extensive construction activities in APAC. Non-residential constructions are the major en …
